IL17A and COVID-19: An elevated level of immunomodulatory cytokines, including IL-1α, IL-1β, IFN-α, IL-17A, and IL-12p70, constitute COVID-19 signature that exhibits dynamic features associated with clinical manifestations (Figure 2) (15, 45).